" class="no-js "lang="en-US"> EVERSANA Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of […]

EVERSANA Unveils Global Price and Market Access Solution NAVLIN by EVERSANA

EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today […]

EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services

EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced […]

EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe

EVERSANA ™, the pioneer of next generation commercial services to the global life sciences industry, today […]

GENinCode Announces Major US Commercialisation Partnership with EVERSANA

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more